| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
56,220,000 |
| Market
Cap: |
9.43(B) |
| Last
Volume: |
1,894,496 |
Avg
Vol: |
592,366 |
| 52
Week Range: |
$99.75 - $201.75 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1272 |
| Guru Rank Value : -4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,589 |
8,911 |
| Total Buy Value |
$0 |
$0 |
$1,251,686 |
$1,499,984 |
| Total People Bought |
0 |
0 |
2 |
2 |
| Total Buy Transactions |
0 |
0 |
2 |
3 |
| Total Shares Sold |
800 |
1,200 |
6,380 |
73,715 |
| Total Sell Value |
$126,080 |
$186,096 |
$1,012,764 |
$17,252,050 |
| Total People Sold |
1 |
1 |
2 |
8 |
| Total Sell Transactions |
1 |
2 |
6 |
22 |
| End Date |
2025-08-17 |
2025-05-16 |
2024-11-15 |
2023-11-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Knell Michael Gunnar |
CSVP, CAO, Interim CFO |
|
2025-11-06 |
4 |
A |
$170.88 |
$499,995 |
D/D |
2,926 |
13,460 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2025-08-18 |
4 |
S |
$157.60 |
$126,080 |
D/D |
(800) |
24,116 |
|
-8% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2025-08-07 |
4 |
S |
$150.04 |
$60,016 |
D/D |
(400) |
24,916 |
|
-13% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2025-06-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
385 |
25,316 |
|
- |
|
Ceesay Abraham |
Director |
|
2025-06-02 |
4 |
A |
$135.04 |
$127,748 |
D/D |
946 |
946 |
|
- |
|
Enyedy Mark J |
Director |
|
2025-06-02 |
4 |
A |
$135.04 |
$127,748 |
D/D |
946 |
946 |
|
- |
|
Barg Steven |
Director |
|
2025-06-02 |
4 |
A |
$135.04 |
$192,702 |
D/D |
1,427 |
1,427 |
|
- |
|
Graves Paul W |
Director |
|
2025-06-02 |
4 |
A |
$135.04 |
$127,748 |
D/D |
946 |
946 |
|
- |
|
Mintz Mark |
EVP, Chief Information Officer |
|
2025-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,350 |
|
27% |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2025-06-01 |
4 |
D |
$135.63 |
$30,517 |
D/D |
(225) |
10,534 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2025-05-31 |
4 |
D |
$135.63 |
$38,383 |
D/D |
(283) |
65,944 |
|
- |
|
Pease Flavia |
Corporate Executive VP & CFO |
|
2025-05-31 |
4 |
D |
$135.63 |
$25,092 |
D/D |
(185) |
17,297 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2025-05-31 |
4 |
D |
$135.63 |
$21,023 |
D/D |
(155) |
25,701 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2025-05-31 |
4 |
D |
$135.63 |
$16,276 |
D/D |
(120) |
22,362 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2025-05-31 |
4 |
D |
$135.63 |
$14,241 |
D/D |
(105) |
12,997 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2025-05-31 |
4 |
D |
$135.63 |
$6,510 |
D/D |
(48) |
10,759 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2025-05-30 |
4 |
A |
$135.63 |
$1,659,976 |
D/D |
12,239 |
66,227 |
|
- |
|
Pease Flavia |
Corporate Executive VP & CFO |
|
2025-05-30 |
4 |
A |
$135.63 |
$970,026 |
D/D |
7,152 |
17,482 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2025-05-30 |
4 |
A |
$135.63 |
$2,340,024 |
D/D |
17,253 |
210,685 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2025-05-30 |
4 |
A |
$135.63 |
$909,942 |
D/D |
6,709 |
25,856 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2025-05-30 |
4 |
A |
$135.63 |
$847,959 |
D/D |
6,252 |
22,482 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2025-05-30 |
4 |
A |
$135.63 |
$759,935 |
D/D |
5,603 |
13,102 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2025-05-30 |
4 |
A |
$135.63 |
$279,940 |
D/D |
2,064 |
10,807 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2025-05-28 |
4 |
D |
$138.65 |
$11,508 |
D/D |
(83) |
19,147 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2025-05-28 |
4 |
D |
$138.65 |
$6,101 |
D/D |
(44) |
7,499 |
|
- |
|
1114 Records found
|
|
Page 1 of 45 |
|
|